期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
微创肿大淋巴结切除手术技巧
1
作者 雷翠蓉 马丽芳 邹冬玲 《中华腔镜外科杂志(电子版)》 2023年第5期299-303,共5页
目的盆腹腔肿大淋巴结常侵犯大血管、神经、输尿管等,切除过程中肿大淋巴结可能破碎,瘤液外渗,且可能出现损伤大血管等情况导致切除失败,以1例局部晚期宫颈癌患者为例,探讨无夹持整块切除肿大淋巴结的微创手术技巧。方法回顾性分析2021... 目的盆腹腔肿大淋巴结常侵犯大血管、神经、输尿管等,切除过程中肿大淋巴结可能破碎,瘤液外渗,且可能出现损伤大血管等情况导致切除失败,以1例局部晚期宫颈癌患者为例,探讨无夹持整块切除肿大淋巴结的微创手术技巧。方法回顾性分析2021年1月在重庆大学附属肿瘤医院妇科肿瘤中心就诊的1例局部晚期宫颈鳞癌ⅢC1r,接受腹主动脉旁淋巴结切除分期手术,术中同时除盆腔肿大淋巴结,术后同步放化疗患者的临床资料。结果患者接受da Vinei Xi机器人微创手术,术中秉承“easy first”原则由简至难逐层推进,根据“隧道原理”钝锐结合稳步分离,保护血管、“保护”淋巴结,间隙出现“热兵器”,紧密贴合“冷兵器”整块切除盆腔巨块淋巴结和腹主动脉旁淋巴结。术中出血少、无损伤,手术病理分期为宫颈鳞癌Ⅲ C2p,术后13 d开始同步放化疗,并在60d内放疗结束,副反应为Ⅰ级胃肠道反应和中性粒细胞减少。治疗后评估达CR,随访两年无异常。结论采用无夹持整块切除方法切除局部晚期宫颈癌盆腹腔肿大淋巴结是安全可行的,可有效避免淋巴结破损导致的肿瘤外溢,减轻瘤负荷,不延长放疗开始的时间。 展开更多
关键词 局部晚期宫颈癌 手术技巧 肿大淋巴结切除
原文传递
New method of lymph node tracing in gastrectomy for advanced gastric carcinoma
2
作者 Huaiwu Jiang Zonglin Li +2 位作者 Jin Chen Shiming Xiao Liang Luo 《The Chinese-German Journal of Clinical Oncology》 CAS 2012年第10期598-601,共4页
Objective: The aim of this study was to explore a new method of lymph node tracing in radical gastrectomy for advanced gastric carcinoma (AGC). Methods: Ninety-two patients who suffered from gastric angle carcinom... Objective: The aim of this study was to explore a new method of lymph node tracing in radical gastrectomy for advanced gastric carcinoma (AGC). Methods: Ninety-two patients who suffered from gastric angle carcinoma with metastasis in No. 3 group lymph nodes were carried out radical gastrectomy. During the operation methylene blue was injected inside or around the circum of the metastatic No. 3 group lymph nodes. Secondary sentinel lymph nodes (SSLNs) were the near- est blue lymph nodes to No. 3 group lymph nodes that were searched in 5 to 10 rain after injecting methylene blue. These SSLNs were resected and carried out hematoxylin-eosin (HE) staining as well as immunohistochemistry (IHC) staining to demonstrate whether there were metastasis. Results: SSLNs were found successfully in 76 patients with a positive rate of 82.6% (76/92) by methylene blue staining, among which, 34 patients were demonstrated existing metastasis in SSLNs by HE staining, 26 patients were demonstrated existing metastasis in SSLNs by IHC staining which were not demonstrated exist- ing metastasis by HE staining. Totally, 60 patients were demonstrated existing metastasis in SSLNs by HE staining and IHC staining with a positive rate of 78.9% (60/76). 136 SSLNs were found in total and 104 SSLNs were demonstrated existing metastasis with a positive rate of 76.4% (104/136). There were 14, 18, 10, 80, 6 and 8 SSLNs in No. 4, No. 5, No. 6, No. 7, No. 8 and No. 9 group lymph nodes respectively. And there were 10, 18, 8, 62, 2 and 4 SSLNs were demonstrated existing metastasis with a positive rate of 71.4%, 100%, 80.0%, 77.5%, 33.3% and 50.0% in No. 4, No~ 5, No. 6, No. 7, No. 8 and No. 9 group lymph nodes respectively. However, there were no significant correlations between the tumor's size and the positive rate of SSLN as well as the degree of tumor's differentiation and the positive rate of SSLN. Conclusion: The technique of SSLN tracing expands the application range of sentinel lymph node (SLN) tracing and provides a new thinking for researching of SLN in AGC. 展开更多
关键词 advanced gastric carcinoma (AGC) secondary sentinel lymph node (SSLN) lymph node tracing
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部